Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hyperprolactinemia and catalepsy induced by haloperidol]

A Reggio, D F Condorelli, D De Simone

    Bollettino Della Societa Italiana Di Biologia Sperimentale
    |August 30, 1981
    PubMed
    Summary

    This study examines how high levels of the hormone prolactin, caused by pituitary gland transplantation, affect the rigid muscle state known as catalepsy triggered by the antipsychotic drug haloperidol in rats. Researchers found that elevated prolactin levels increased the severity of haloperidol-induced muscle rigidity at lower drug doses, but this effect disappeared at higher doses.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Observation of Collider Neutrinos without Final State Muons with the SND@LHC Experiment.

    Physical review letters·2025
    Same author

    Observation of Exotic J/ψϕ Resonant Structure in Diffractive Processes in Proton-Proton Collisions.

    Physical review letters·2025
    Same author

    Modification of χ_{c1}(3872) and ψ(2S) Production in pPb Collisions at sqrt[s_{NN}]=8.16  TeV.

    Physical review letters·2024
    Same author

    Amplitude Analysis of the B^{0}→K^{*0}μ^{+}μ^{-} Decay.

    Physical review letters·2024
    Same author

    Fraction of χ_{c} Decays in Prompt J/ψ Production Measured in pPb Collisions at sqrt[s_{NN}]=8.16  TeV.

    Physical review letters·2024
    Same author

    Enhanced Production of Λ_{b}^{0} Baryons in High-Multiplicity pp Collisions at sqrt[s]=13  TeV.

    Physical review letters·2024

    Area of Science:

    • Neuropharmacology and Hyperprolactinemia research within behavioral neuroscience
    • Endocrine physiology and movement disorder models

    Background:

    The precise interaction between elevated prolactin levels and antipsychotic-induced motor side effects remains poorly understood in clinical settings. Prior research has shown that dopamine receptor antagonists often trigger rigid muscle states in animal models. That uncertainty drove investigators to explore how hormonal shifts influence these specific behavioral responses. No prior work had resolved whether pituitary-derived hormones modulate the intensity of drug-induced movement disorders. Scientists previously established that pituitary transplantation effectively elevates systemic hormone concentrations in rodent subjects. This gap motivated a closer look at the physiological consequences of such endocrine alterations. Researchers recognized that existing data regarding hormonal influence on motor control required further validation. This study addresses the missing link between chronic endocrine status and acute pharmacological responses.

    Purpose Of The Study:

    The aim of this study was to evaluate the impact of endogenous hyperprolactinemia on the development of catalepsy induced by haloperidol. Researchers sought to determine if elevated prolactin levels alter the motor side effects commonly associated with antipsychotic drug administration. The investigation focused on whether hormonal status modifies the sensitivity of the extrapyramidal system to dopamine receptor blockade. By utilizing a pituitary transplantation model, the team aimed to isolate the effects of chronic hormone elevation. This study addresses the uncertainty regarding how endocrine factors contribute to individual variability in drug-induced movement disorders. The researchers were motivated by the need to clarify the relationship between prolactin and motor rigidity in a controlled setting. No prior work had resolved the specific dose-dependent nature of this interaction in rodent models. This work provides a foundation for understanding the interplay between hormonal status and pharmacological responses in the nervous system.

    Keywords:
    pituitary transplantationdopamine receptor antagonistsmotor side effectsendocrine regulation

    Frequently Asked Questions

    The researchers propose that elevated prolactin levels potentiate the cataleptic score in rats receiving 500 gamma/kg of haloperidol. This indicates that the endocrine state enhances the motor rigidity triggered by lower concentrations of the dopamine antagonist.

    The study utilized pituitary transplantation under the kidney capsule to induce endogenous hyperprolactinemia. This surgical technique ensures a constant, elevated release of prolactin into the systemic circulation compared to control subjects.

    The researchers performed assessments every five minutes by placing the animal's forepaw on a horizontal bar. This standardized procedure allowed for the observation of muscle rigidity over a two-minute interval following the administration of the drug.

    The study used male Wistar rats weighing 220 +/- 30 grams. These subjects received intraperitoneal injections of haloperidol at two distinct doses to compare the behavioral outcomes between the experimental and control groups.

    Related Experiment Videos

    Main Methods:

    Review approach involved evaluating behavioral responses in male Wistar rats following specific surgical and pharmacological interventions. Investigators performed pituitary transplantation under the kidney capsule to establish a model of chronic endocrine elevation. The team administered two distinct doses of the antipsychotic agent to assess motor rigidity. Researchers utilized a horizontal bar test to quantify the severity of the cataleptic state. Observations occurred every five minutes for a duration of two minutes per assessment point. The experimental design compared these results against control groups lacking the pituitary transplant. Statistical analysis focused on identifying differences in motor scores between the two hormonal conditions. This systematic approach allowed for the isolation of hormonal variables in the context of drug-induced movement disorders.

    Main Results:

    Key findings from the literature reveal that elevated prolactin levels significantly increase the cataleptic score in rats treated with 500 gamma/kg of haloperidol. This potentiation demonstrates a clear interaction between the hormonal state and the lower dose of the antipsychotic drug. Conversely, the study observed no significant difference in cataleptic responses between hyperprolactinemic and control rats when the dose was increased to 2 mg/kg. These results suggest that the hormonal impact on motor rigidity is not uniform across all pharmacological concentrations. The data indicate that the endocrine influence is most pronounced at lower levels of dopamine receptor blockade. Higher doses of the drug appear to override the modulatory effects of the elevated hormone. The researchers documented these behavioral changes through consistent monitoring of the subjects on the horizontal bar. This pattern of results underscores the complexity of neuroendocrine and pharmacological interactions in motor control.

    Conclusions:

    The authors propose that elevated prolactin levels significantly amplify the motor rigidity caused by low-dose haloperidol administration. Synthesis and implications suggest that hormonal status modulates the sensitivity of the extrapyramidal system to dopamine antagonism. These findings indicate that the observed potentiation depends heavily on the specific dosage of the administered antipsychotic agent. The researchers conclude that high prolactin levels do not alter the cataleptic response when the drug dose reaches a higher threshold. This suggests a ceiling effect where the pharmacological impact overrides the underlying endocrine influence. The evidence implies that clinical management of antipsychotic side effects might require consideration of a patient's baseline hormonal profile. These results provide a framework for understanding how endocrine factors contribute to individual variability in drug-induced movement disorders. The study highlights the complex interplay between neuroendocrine regulation and motor function in a controlled animal model.

    The cataleptic score was measured by observing the duration the rat maintained an awkward posture on a horizontal bar. This behavioral metric quantifies the intensity of the muscle rigidity induced by the dopamine receptor antagonist.

    The authors suggest that the hormonal influence on motor side effects is dose-dependent. They propose that the potentiating effect of prolactin is masked or absent when higher doses of haloperidol are administered to the subjects.